HMG-CoA reductase inhibitor treatment in renal insufficiency

被引：7
|
作者：
Wanner, C
机构：
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 1996年 / 11卷 / 10期
关键词：
D O I：
10.1093/oxfordjournals.ndt.a027076
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
引用
收藏
页码：1951 / 1952
页数：2
相关论文
共 50 条
  • [21] Newer HMG-CoA reductase inhibitor (statin) therapies
    Brinton, EA
    CLINICAL CARDIOLOGY, 2001, 24 (07) : II10 - II13
  • [22] INHIBITION OF CHOLESTEROL ABSORPTION BY HMG-COA REDUCTASE INHIBITOR
    MIETTINEN, TA
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 40 : S19 - S21
  • [23] Rosuvastatin - A new HMG-CoA reductase inhibitor for hypercholesterolemia
    Roach, AE
    Tsikouris, JP
    Haase, KK
    FORMULARY, 2002, 37 (04) : 179 - +
  • [24] Design of Tripeptides as a Competitive Inhibitor for HMG-CoA Reductase
    Pak, Valeriy V.
    Kwon, Dae Yong
    Khojimatov, Olim K.
    Pak, Aleksandr, V
    Sagdullaev, Shomansur Sh
    INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS, 2021, 27 (03) : 1923 - 1931
  • [25] HMG-CoA reductase inhibitor-induced impotence
    Halkin, A
    Lossos, IS
    Mevorach, D
    ANNALS OF PHARMACOTHERAPY, 1996, 30 (02) : 192 - 192
  • [26] Renal tubular toxicity of HMG-CoA reductase inhibitors
    van Zyl-Smit, R
    Firth, JC
    Duffield, M
    Marais, AD
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 (12) : 3176 - 3179
  • [27] HMG-COA REDUCTASE INHIBITORS
    ENDO, A
    ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY, 1985, 183 : 295 - 310
  • [28] Chronic creatine kinase elevation not associated with HMG-CoA reductase inhibitor treatment
    Lin, JC
    Ito, MK
    ANNALS OF PHARMACOTHERAPY, 1999, 33 (02) : 163 - 166
  • [29] HMG-COA REDUCTASE INHIBITORS
    ENDO, A
    HASUMI, K
    NATURAL PRODUCT REPORTS, 1993, 10 (06) : 541 - 550
  • [30] HMG-CoA reductase inhibitors
    Illingworth, DR
    Tobert, JA
    ADVANCES IN PROTEIN CHEMISTRY, VOL 56: DRUG DISCOVERY AND DESIGN, 2001, 56 : 77 - 114
12345